Search results for "Platelet"

showing 10 items of 786 documents

Abciximab Facilitates the Rate and Extent of Thrombolysis

1999

Background —The TIMI 14 trial tested the hypothesis that abciximab, the Fab fragment of a monoclonal antibody directed to the platelet glycoprotein (GP) IIb/IIIa receptor, is a potent and safe addition to reduced-dose thrombolytic regimens for ST-segment elevation MI. Methods and Results —Patients (n=888) with ST-elevation MI presenting <12 hours from onset of symptoms were treated with aspirin and randomized initially to either 100 mg of accelerated-dose alteplase (control) or abciximab (bolus 0.25 mg/kg and 12-hour infusion of 0.125 μg · kg −1 · min −1 ) alone or in combination with reduced doses of alteplase (20 to 65 mg) or streptokinase (500 000 U to 1.5 MU). Control patients recei…

business.industrymedicine.medical_treatmentStreptokinaseReteplaseThrombolysismedicine.diseaseBolus (medicine)Physiology (medical)AnesthesiamedicineAbciximabPlatelet aggregation inhibitorMyocardial infarctionCardiology and Cardiovascular MedicinebusinessTIMImedicine.drugCirculation
researchProduct

Role of genetic polymorphisms in myocardial infarction at young age

2010

Acute myocardial infarction (AMI) in young adult presents a typical pattern of risk factors, clinical, angiographic and prognostic characteristics. In the last years we demonstrated that hemorheological profile is altered in these patients in a persistent way and independently of the number of risk factors and of the extent of coronary lesions. Thus, the hyperviscosity syndrome following AMI could be considered an intrinsic characteristic of these patients. Consequently it is possible to hypothesise the presence of a genetic background at the origin of this predisposition. If this background is able to influence the risk of ischemic heart disease, this should be particularly evident in youn…

cardiovascular risk factorsAdultMalePathologymedicine.medical_specialtyPhysiologyPopulationMyocardial InfarctionCoronary DiseaseSingle-nucleotide polymorphismDiseaseBiologyPolymorphism Single NucleotideConnexinsPhysiology (medical)Genetic predispositionmedicineHumansSNPGenetic Predisposition to DiseaseMyocardial infarctionAlleleeducationAged 80 and overInflammationeducation.field_of_studyHaplotypeHematologyMiddle AgedPyrinmedicine.diseaseInterleukin-10Platelet Endothelial Cell Adhesion Molecule-1Toll-Like Receptor 4Juvenile myocardial infarctiongenetic patternCytoskeletal ProteinsC-Reactive ProteinImmunologyFemaleCardiology and Cardiovascular MedicineClinical Hemorheology and Microcirculation
researchProduct

Different metabolic behavior of long-chain n-3 polyunsaturated fatty acids in human platelets.

1988

Abstract Whereas numerous studies deal with the effects and metabolism of eicosapentaenoic acid (20:5( n −3)) in platelets, very few concern docosahexaenoic acid (22:6( n −3)), although both acids are consumed in equal amounts from most fish fat. The present paper reports the modulation of 22:6( n −3) oxygenation as well as that of endogenous arachidonic acid (20:4( n −6)) in 22:6( n −3)-rich platelets. Like the oxygenation of 20:5( n −3), the lipoxygenation of 22:6( n −3) occurred at a low level when incubated alone, but was markedly increased in the presence of 20:4( n −6), suggesting a similar peroxide tone dependency. 20:5( n −3) could not replace 20:4( n −6) in the increasing 22:6( n −…

chemistry.chemical_classificationBlood PlateletsbiologyDocosahexaenoic AcidsChemistryLipoxygenaseBiophysicsThromboxanesMetabolismArachidonic AcidsIn Vitro TechniquesBiochemistryEicosapentaenoic acidLipoxygenasechemistry.chemical_compoundEndocrinologyBiochemistryEicosapentaenoic AcidDocosahexaenoic acidbiology.proteinHumansPlateletArachidonic acidUnsaturated fatty acidPolyunsaturated fatty acidBiochimica et biophysica acta
researchProduct

Non-steroidal anti-inflammatory agents. Part 23. Synthesis and Pharmacological Activity of Enaminones which inhibit both bovine cyclooxygenase and 5-…

1998

The synthesis and stereochemical characteristics of pyrrolidino-, isoquinolino- and indolo-enaminones 2–11 are reported. The inhibition of cyclooxygenase was determined in a bovine thrombocyte intact cell assay and that of 5-lipoxygenase using intact bovine polymorphonuclear leucocytes. Except compound 2c′ which is a well-balanced dual inhibitor of both enzymes, all other enaminone derivatives are weak inhibitors of both cyclooxygenase and 5-lipoxygenase. Structure-activity relationships of the enaminones in relation to known anti-inflammatory drugs are discussed.

chemistry.chemical_classificationEnzymebiologychemistryNon steroidal anti inflammatoryArachidonate 5-lipoxygenasebiology.proteinDual inhibitorPlateletBiological activityIntact cellCyclooxygenasePharmacologyJournal f�r Praktische Chemie/Chemiker-Zeitung
researchProduct

Effect of the elongational flow on morphology and properties of polypropylene/graphene nanoplatelets nanocomposites

2018

Abstract In this work the effect of the presence of graphene nanoplatelets (GnP) on the morphology and mechanical properties of polypropylene/GnP nanocomposites has been investigated when these polymer systems are subjected to non-isothermal elongational flow in a melt spinning operation. The presence of the GnP magnifies the effect of the elongational flow. Indeed, the elastic modulus and the tensile strength of nanocomposites increases with the orientation more than that observed for the pure matrix. Moreover, the elongation at break increases at low values of the draw ratio for the nanocomposites, while, the matrix shows the expected decrease in deformability. These effects have been cor…

chemistry.chemical_classificationPolypropyleneNanocompositeMaterials scienceNanocompositePolymers and PlasticsOrganic Chemistry02 engineering and technologyPolymer010402 general chemistry021001 nanoscience & nanotechnology01 natural sciences0104 chemical scienceschemistry.chemical_compoundchemistryPhase (matter)Ultimate tensile strengthGraphene nanoplatelets (GnP)FiberMelt spinningComposite materialPolypropylene0210 nano-technologyContact areaElastic modulusPolymer Testing
researchProduct

Acides gras des phospholipides plaquettaires et des lipides plasmatiques chez le rat obése Zucker

1988

AbstractThe purpose of this work was to see whether hyperlipaemia observed in genetically obese Zucker rats (fa/fa) was associated with differences in fatty-acid composition of plasma triacylglycerols, plasma phospholipids and of platelet phospholipids, in comparison with the control lean rats (Fa/-).Results showed that plasma triacylglycerols and phospholipids were increased in obese rats. In triacylglycerols, the amount of saturated and monounsaturated fatty acids was highly increased whereas the amount of the n-6 and n-3 polyunsaturated fatty acids was little modified. In plasma phospholipids, saturated and monounsaturated fatty acids were also increased, as were the n-3 fatty acids (exc…

chemistry.chemical_classificationmedicine.medical_specialtyPhysiologyLinoleic acidFatty acidBiochemistrychemistry.chemical_compoundEndocrinologychemistryInternal medicinemedicinelipids (amino acids peptides and proteins)Composition (visual arts)PlateletZucker RatsPolyunsaturated fatty acidArchives Internationales de Physiologie et de Biochimie
researchProduct

Microcirculatory Dysfunction Induced by Cigarette Smoking

2000

This review deals with the deleterious effects of cigarette smoking on the microcirculation, both in terms of morphological (i.e., vessel wall injury, capillary loss) and functional aspects. The latter concerns predominantly changes in tissue perfusion and its regulatory mechanisms (i.e., reactive hyperemia, sequestration of blood cells in the microcirculation). The mechanisms of action of cigarette smoking on the microcirculation include compromised endothelial-dependent vasorelaxation, platelet aggregation, endothelial cell dysfunction, and the activation of circulating leukocytes. Through these mechanisms, cigarette smoking elicits the aggregation and adhesion of leukocytes and/or platel…

chemistry.chemical_classificationmedicine.medical_specialtyReactive oxygen speciesPathologyPhysiologybusiness.industryCell adhesion moleculeHamsterMicrocirculationEndothelial stem cellEndocrinologychemistryPhysiology (medical)Internal medicinemedicinePlateletCardiology and Cardiovascular MedicinebusinessMolecular BiologyReactive hyperemiaPerfusionMicrocirculation
researchProduct

Implication of eNOS Uncoupling in Cardiovascular Disease

2017

Under physiological conditions, nitric oxide (NO) is produced in the vasculature mainly by the endothelial nitric oxide synthase (eNOS). Endothelial NO relaxes blood vessels, inhibits platelet activity, and protects against atherosclerosis. Under pathological conditions such as hypertension, diabetes, and hypercholesterolemia, eNOS may become uncoupled. Uncoupled eNOS generates superoxide at the expense of NO and contributes substantially to oxidative stress and endothelial dysfunction. Major mechanisms of eNOS uncoupling include deficiency of the eNOS cofactor tetrahydrobiopterin, deficiency of the eNOS substrate L-arginine, and eNOS S-glutathionylation. Reversal of eNOS uncoupling may rep…

chemistry.chemical_classificationmedicine.medical_specialtyReactive oxygen speciesbiologybusiness.industrySuperoxideTetrahydrobiopterinbiology.organism_classificationmedicine.disease_causemedicine.diseaseNitric oxidechemistry.chemical_compoundEndocrinologychemistryEnosInternal medicinemedicinePlatelet activationEndothelial dysfunctionbusinessOxidative stressmedicine.drugReactive Oxygen Species
researchProduct

Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes

2022

The treatment of acute coronary syndrome (ACS) in elderly patients continues to be a challenge because of the characteS.G.B.ristics of this population and the lack of data and specific recommendations. This review summarizes the current evidence about critical points of oral antithrombotic therapy in elderly patients. To this end, we discuss the peculiarities and differences reported referring to dual antiplatelet therapy (DAPT) in ACS management in elderly patients and what might be the best option considering these population characteristics. Furthermore, we analyze antithrombotic strategies in patients with atrial fibrillation (AF), with a particular focus on those cases that also presen…

clopidogrelHeart diseasesGerontologíaEnfermedad cardiovascularGeneral MedicineCardiologíaClorhidrato de prasugrelelderlyantiplatelet therapyMalalties del coracute coronary syndromeprasugrelticagrelorAnticoagulants (Medicina)Síndrome coronario agudoAnticoagulants (Medicine)
researchProduct

Enhanced Lipid Peroxidation and Platelet Activation in the Early Phase of Type 1 Diabetes Mellitus

2003

Background— To investigate early events possibly related to the development of diabetic angiopathy, we examined whether 8-iso-prostaglandin F 2α (8-iso-PGF 2α ) formation, a marker of in vivo oxidant stress, is altered in different stages of type 1 diabetes (T1DM) and whether it correlates with the rate of thromboxane (TX) A 2 biosynthesis, a marker of in vivo platelet activation. We also investigated the relationship between inflammatory markers and F 2 -isoprostane formation in this setting. Methods and Results— A cross-sectional study was performed in 23 insulin-treated patients aged <18 years with new-onset T1DM (≤6 weeks, group A), matched for age and gender with 23 patients with s…

diabetes mellitus; inflammation; plateletsMalemedicine.medical_specialtyAdolescentThromboxaneInflammationDiabetic angiopathyDinoprostTimeThromboxane A2Reference ValuesPhysiology (medical)Internal medicineDiabetes mellitusHumansInsulinMedicinePlatelet activationChildInterleukin 6InflammationF2-IsoprostanesType 1 diabetesbiologyInterleukin-6Tumor Necrosis Factor-alphabusiness.industryPlatelet Activationmedicine.diseaseThromboxane B2Oxidative StressC-Reactive ProteinCross-Sectional StudiesDiabetes Mellitus Type 1Endocrinologydiabetes mellitusplateletsDisease Progressionbiology.proteinFemaleTumor necrosis factor alphaLipid Peroxidationmedicine.symptomCardiology and Cardiovascular MedicinebusinessBiomarkersFollow-Up StudiesCirculation
researchProduct